52 
Insulet Expands its Offering of Omnipod DASH® Insulin Management System
BioTech 365
SEPTEMBER 21, 2020
ACTON, Mass.–(BUSINESS
Insulin Related Topics 
Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market
XTalks
SEPTEMBER 23, 2020
Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections.
Join
thousands
INSIDERS
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025 – ResearchAndMarkets.com
BioTech 365
SEPTEMBER 8, 2020
DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025” report has been added to ResearchAndMarkets.com’s offering. “Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025” Report Highlights: Diabetes Drug Market Opportunity: > … Continue reading → Business Wire
Five Top Drugmakers Reveal List vs. Net Price Gaps (Plus: The Trouble With Insulin Prices)
Drug Channels
AUGUST 11, 2020
As the companies’ insulin data illustrate below, the bubble raises costs for patients who are not always benefiting from lower net selling prices. Time for our annual update on pricing at five of the largest pharmaceutical manufacturers—Eli Lilly, Janssen, Merck, Novartis, and Sanofi.
Capillary Biomedical Receives $1.5 Million from Helmsley Charitable Trust for Clinical Trials of New Insulin Infusion Technology
BioTech 365
OCTOBER 7, 2020
Funding to fuel testing of extended-wear SteadiFlow technology designed to reduce infusion site failures and improve quality of life for people with diabetes IRVINE, Calif.–(BUSINESS –(BUSINESS WIRE)–Capillary Biomedical, Inc. CapBio) has announced that it has received a $1.5 million program-related investment … Continue reading → Business Wire
HHS Insulin Import RFP Misinterprets the Law: Reimportation vs Importation
Pharmacy Checkers
OCTOBER 9, 2020
Today, I’m going to get very, very nerdy about the new Request For Proposals issued to allow for the reimportation of insulin. Flash forward to the new Insulin RFP. It specifically does not allow importation of FDA-approved insulin made elsewhere to be imported!
Medtronic Introduces New Minimed 770G For Type 1 Diabetes
XTalks
SEPTEMBER 3, 2020
This is an insulin pump system that offers the company’s most advanced SmartGuard technology. ” The pancreas of people with type 1 diabetes cannot produce insulin.
Insulet Appoints Wayne A. I. Frederick, M.D., to Board of Directors
BioTech 365
OCTOBER 20, 2020
–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that Wayne A. ACTON, Mass.–(BUSINESS
Researchers Develop Potential Breakthrough in Type 1 Diabetes Treatment
BioSpace
AUGUST 19, 2020
Researchers from the Salk Institute took a major step forward in developing a new insulin-producing pancreatic cell cluster as a potential treatment for type 1 diabetes patients
Insulet to Announce Third Quarter 2020 Financial Results on November 4, 2020
BioTech 365
OCTOBER 5, 2020
ACTON, Mass.–(BUSINESS
Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year
BioTech 365
AUGUST 6, 2020
Includes Total Omnipod® Revenue Growth of 26% ACTON, Mass.–(BUSINESS
Dollars, Deductibles, and Drugs: Discovering the Costs of Living with Type 2 Diabetes
Science 37
JULY 13, 2018
Finally, in frustration, I emptied the bag containing all the items I received (pamphlets on diabetes, alcohol wipes, insulin pens, and more), and dumped them on my bed. The impact of financial toxicity on the diabetes community is a serious problem, and I haven’t even mentioned the price of insulin. Diabetes diabetes diabetes costs financial toxicity health disparities insulin type 2 diabetesSlapped With the Price Tag.
CA Governor Looks to Disrupt State’s Generics Market to Promote Affordability
BioSpace
SEPTEMBER 29, 2020
Gavin Newsom signed Senate Bill 852 into law on Monday, paving the way for California to manufacture cheaper versions of insulin and other drugs that have been in short supply in recent years California Gov.
Understanding beta cell growth may help treat diabetes
Scienmag
OCTOBER 1, 2020
Study will examine ways a single enzyme controls cell size and insulin production BATON ROUGE, Louisiana – New treatments for metabolic diseases, such as type 2 diabetes, could emerge from a study of how a single enzyme controls the growth of the pancreatic cells that produce insulin.
In the News: September Regulatory and Development Updates
Camargo
OCTOBER 14, 2020
The FDA has announced its approval of a bluetooth-controlled insulin delivery and monitoring system for use in pediatric patients ages 2 through 6 with Type 1 diabetes.
Arecor to Present at EASD 2020
BioTech 365
SEPTEMBER 21, 2020
ORAL PRESENTATION OF PHASE I CLINICAL TRIAL OF AT247, A NOVEL ULTRA RAPID ACTING INSULIN CAMBRIDGE, United Kingdom, Sept. 21, 2020 (GLOBE NEWSWIRE) — Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces … Continue reading → GlobeNewswire
Move over Akita: Introducing ‘Kuma mutant’ mice for islet transplantation research
Scienmag
AUGUST 5, 2020
But when it does, it’s mostly due to a mutation in a single gene such as the KCNJ11 or insulin (INS). Credit: Tokyo Tech Diabetes seldom occurs in newborns–a condition known as neonatal diabetes.
Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Scienmag
SEPTEMBER 29, 2020
Patients given sitagliptin in addition to insulin had a mortality rate […]. Sitagliptin blocks coronavirus from entering cells, reduces inflammation; observational findings have sparked a placebo-controlled trial BOSTON – Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.
Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?
XTalks
SEPTEMBER 15, 2020
The trial showed a preservation of function of insulin-producing ?-cells The vaccine – trademarked as Diamyd – is an antigen-specific immunotherapy that helps to preserve endogenous insulin production.
Health2Sync and Sanofi to digitally manage diabetes in Taiwan
Pharma Phorum
SEPTEMBER 17, 2020
But use of insulin is relatively low compared with American and European countries and there are an estimated 2.2 The ultimate goal is to improve patients’ understanding of insulin, increase glucose control and raise the insulinisation rate in Taiwan.
Novo Nordisk beats Q2 profit forecasts by cutting costs
Pharma Phorum
AUGUST 6, 2020
The company’s diabetes care products saw an increase in sales during the second quarter, although this was offset by lower sales of insulin. Insulins are still important for Novo Nordisk, bringing in sales of 29.5
Arthritis drug Abatacept could be used to treat type 1 diabetes
The Pharma Data
AUGUST 11, 2020
Type 1 diabetes sees patients lose insulin over time which shortens their lifespan. Abatacept preserves the pancreas’s ability to produce insulin which could help diabetics live longer. Photo by Jessica Merz from Novato, USA.
Working in pharma
World of DTC Marketing
AUGUST 16, 2020
The CEO of Lilly who took a dollar as salary when we lost patent protection on our top drug was replaced by an atmosphere of weeding out older employees and scrapping new ideas that could be a real benefit to patients while at the same time raising pricing on insulin.
My Wall Street Journal Op-Ed about the 340B Program
Drug Channels
SEPTEMBER 15, 2020
Last Friday, The Wall Street Journal published my opinion piece: The Federal Program That Keeps Insulin Prices High. The article text is pasted below for those who don't subscribe. I summarize issues with the role of contract pharmacies in the 340B Drug Pricing Program.
Obesity increases risk of death from coronavirus and could make vaccines less effective
The Pharma Data
AUGUST 27, 2020
People with obesity are also far more likely to have underlying health conditions such as heart disease and type 2 diabetes, and it can also cause insulin resistance and inflammation which makes it harder for the body to fight off infections.
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharma Phorum
SEPTEMBER 1, 2020
The most common adverse reactions were nausea, diarrhoea and hypoglycemia when used with insulin and/or sulfonylurea. Novo Nordisk has launched its type 2 diabetes pill Rybelsus (semaglutide) in the UK, after cost-effectiveness watchdog NICE decided that there was no need to review it.
Walgreens and CVS Top the 28,000 Pharmacies Profiting from the 340B Program. Will the Unregulated Party End? (rerun)
Drug Channels
SEPTEMBER 2, 2020
However, Lilly will permit its insulin to be dispensed from 340B contract pharmacies—as long as patients receive the discounted 340B prices of $0.03
Shake diet offered on NHS to fight type 2 diabetes
The Pharma Data
SEPTEMBER 1, 2020
It is caused by problems with a chemical in the body (hormone) called insulin. Image copyright. Getty Images. Thousands more people in England with type 2 diabetes will be offered the chance to try a soup-and-shake diet weight-loss plan for free on the NHS.
Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes
Pharma Phorum
AUGUST 11, 2020
Novo Nordisk is itself investing in such technology, and is aiming to introduce more connected devices, such as digital insulin pens, in the future.
Risk Assessment Tool Identifies Diabetic Patients that Benefit Most from SGLT2 Inhibitor Treatment
XTalks
SEPTEMBER 22, 2020
Compared to other anti-diabetic drugs, such as sulfonylurea derivatives and insulin, SGLT2 inhibitors are associated with a low risk of hypoglycaemia.
14 BEST IBS Medication Over The Counter
Druggist
OCTOBER 4, 2020
Irritable bowel syndrome (IBS) is a common condition which is characterised by smooth muscle spasm alongside the gastrointestinal tract with a range of associated symptoms. Patients who are diagnosed with IBS are usually advised on the lifestyles to minimise the risk of IBS symptoms.
FDA rejects BioMarin’s Valoctocogene Roxaparvovec; J&J inks $6.5B deal; Alzheon bags $47M; Research updates on diabetes
Delveinsight
AUGUST 20, 2020
Generating insulin-producing pancreatic beta cells from stem cells to substitute those damaged by the immune system is a promising approach for diabetes treatment. FDA rejects BioMarin’s gene therapy and Gilead’s filgotinib over concerns.
NAFLD & NASH Clinical Trials: Viking Therapeutics Reports Positive Phase II Trial Data
XTalks
SEPTEMBER 2, 2020
NAFLD is part of the metabolic syndrome that is characterized by diabetes, or pre-diabetes (insulin resistance), which includes being overweight or obese, elevated blood lipids such as cholesterol and triglycerides, as well as high blood pressure.
How Trump’s Canadian Drug Importation Executive Order Changes Things
Pharmacy Checkers
JULY 28, 2020
2) Allow for the re-importation of insulin. The part of the executive order specific to insulin could be a game changer more immediately. The executive order seems to state that the price of insulin is an emergency, and that’s unambiguously true.
Understand Executive Authority on Allowing Safe Personal Drug Importation
Pharmacy Checkers
JULY 25, 2020
Originally Published as A Blueprint to Understand Executive Authority on Allowing Safe Personal Drug Importation on PrescriptionJustice.org. Yesterday, President Trump announced four executive orders with the stated intent of substantially lowering drug prices.
Trump’s Executive Orders on Drug Pricing: The Drug Channels Guide to Industry Implications
Drug Channels
JULY 26, 2020
They cover: Pass-through of 340B discounts for insulin and EpiPens Rebate reform (!) Surprise! President Trump signed four executive orders (EO) last Friday afternoon. Importation Most Favored Nation (MFN) pricing for drugs The fourth order on MFN has not been publicly released, so I will reserve comment for now. I see significant challenges in implementing these far-reaching orders.
Trump approves plan to make the import of Canadian drugs easier
The Pharma Data
SEPTEMBER 25, 2020
It also proposed a rule to allow low-income Americans to purchase affordable insulin and Epi-Pens at nearly 10,000 Federal clinical locations. . Gage Skidmore from Peoria, AZ, United States of America.
Non-Partisan Support of Prescription Drug Importation State Laws Deviate from the National Political Norm
Pharmacy Checkers
JUNE 27, 2019
Finally, there’s the Affordable Insulin Act, H.R. 1478 , which would make it legal to import insulin from Canada. If interested, I wrote at length about caravans to Canada to buy insulin and possible actions activists could take to help people safely import insulin through mail-order pharmacy. Trump supports prescription drug importation, and he’s not alone.
Unpleasant truth: the pandemic, record debt and our opportunity for sustainability
Pharma Phorum
SEPTEMBER 8, 2020
9 US Food and Drug Administration, ‘statement on efforts to help make development of biosimilar and interchangeable insulin products more efficient’.
COVID-19 drives a new era of self-care
Pharma Phorum
OCTOBER 2, 2020
New research shows that the COVID-19 pandemic is encouraging people to take their health into their own hands, and experts say this trend towards self-care could be a significant boon for healthcare systems – one the pharma industry should be encouraging.
Let's personalize your content